Ronald T Riley Selected Research

Neoplasms (Cancer)

1/2019

Ceramide synthase inhibition by fumonisins: a perfect storm of perturbed sphingolipid metabolism, signaling, and disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ronald T Riley Research Topics

Disease

7	Neural Tube Defects (Exencephaly) 01/2022 - 04/2004
3	Growth Disorders 01/2018 - 01/2008
2	Carcinogenesis 09/2016 - 10/2012
1	Inflammation (Inflammations) 01/2023
1	Neoplasms (Cancer) 01/2019
1	Sphingolipidoses (Sphingolipidosis) 01/2019
1	Esophageal Neoplasms (Esophageal Cancer) 11/2018
1	Hepatocellular Carcinoma (Hepatoma) 04/2018
1	Liver Diseases (Liver Disease) 04/2018
1	Infections 05/2014
1	Fetal Weight 12/2009
1	Body Weight (Weight, Body) 12/2009
1	Fetal Death 12/2009
1	Hepatomegaly 01/2006
1	Congenital Abnormalities (Deformity) 04/2004
1	Necrosis 05/2002
1	Animal Diseases 02/2002

Drug/Important Bio-Agent (IBA)

11	FumonisinsIBA 01/2023 - 04/2004
5	fumonisin B1IBA 09/2016 - 02/2002
4	AflatoxinsIBA 01/2023 - 01/2017
3	MycotoxinsIBA 01/2023 - 01/2017
3	SphingolipidsIBA 10/2012 - 04/2004
2	Folic Acid (Vitamin M)FDA LinkGeneric 06/2014 - 04/2004
2	CarcinogensIBA 10/2012 - 02/2002
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	NeopterinIBA 01/2023
1	Peroxidase (Myeloperoxidase)IBA 01/2023
1	AlbuminsIBA 01/2018
1	Aflatoxin B1 (Aflatoxin B)IBA 09/2016
1	Fingolimod Hydrochloride (FTY720)FDA Link 03/2016
1	OchratoxinsIBA 05/2014
1	PPAR alphaIBA 01/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2002